Equities
Health CarePharmaceuticals & Biotechnology
  • Price (EUR)18.41
  • Today's Change-0.07 / -0.38%
  • Shares traded391.66k
  • 1 Year change27.23%
  • Beta0.9137
Data delayed at least 15 minutes, as of Jan 18 2018 16:35 GMT.
More ▼

Key statistics

On Thursday, Erytech Pharma SA (ERYP:PAR) closed at 18.41, 52.15% above the 52 week low of 12.10 set on Feb 10, 2017.
52-week range
Today
12.10Feb 10 201730.20Apr 05 2017
Markit short selling activity
Low
Med
High
Open18.65
High18.65
Low18.25
Bid18.25
Offer18.65
Previous close18.41
Average volume76.12k
Shares outstanding17.93m
Free float17.49m
P/E (TTM)--
Market cap331.43m EUR
EPS (TTM)-2.85
EUR
Data delayed at least 15 minutes, as of Jan 18 2018 16:35 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.